awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40971388-14C4AAFB-9F5C-4AFA-8F9B-D0E789805127
Q40971388-14C4AAFB-9F5C-4AFA-8F9B-D0E789805127
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40971388-14C4AAFB-9F5C-4AFA-8F9B-D0E789805127
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
P2860
Q40971388-14C4AAFB-9F5C-4AFA-8F9B-D0E789805127
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40971388-14C4AAFB-9F5C-4AFA-8F9B-D0E789805127
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fdfca20d5f38d53f55ee42a19d16dc2ff57c7ee5
P2860
Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia.